{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:44:22Z","timestamp":1792626262863,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08605"],"award-info":[{"award-number":["JP21K08605"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08605"],"award-info":[{"award-number":["JP21K08605"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08605"],"award-info":[{"award-number":["JP21K08605"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"DOI":"10.1007\/s00383-024-05863-1","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T13:03:00Z","timestamp":1730206980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dipeptidyl peptidase IV inhibitors reduce hepatic fibrosis and lipid accumulation in rat intestinal failure-associated liver disease models"],"prefix":"10.1007","volume":"40","author":[{"given":"Ryo","family":"Sueyoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marumi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"5863_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1056\/NEJMra1602650","volume":"377","author":"CP Duggan","year":"2017","unstructured":"Duggan CP, Jaksic T (2017) Pediatric intestinal failure. N Engl J Med 377:666\u2013675. https:\/\/doi.org\/10.1056\/NEJMra1602650","journal-title":"N Engl J Med"},{"key":"5863_CR2","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.clnu.2018.07.006","volume":"37","author":"S Lal","year":"2018","unstructured":"Lal S, Pironi L, Wanten G et al (2018) Clinical approach to the management of intestinal failure associated liver disease (IFALD) in adults: a position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN. Clin Nutr 37:1794\u20131797. https:\/\/doi.org\/10.1016\/j.clnu.2018.07.006","journal-title":"Clin Nutr"},{"key":"5863_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s40746-019-00179-y","volume":"5","author":"BA Shakhsheer","year":"2019","unstructured":"Shakhsheer BA, Warner BW (2019) Short bowel syndrome. Curr Treat Options Pediatr 5:494\u2013505. https:\/\/doi.org\/10.1007\/s40746-019-00179-y","journal-title":"Curr Treat Options Pediatr"},{"key":"5863_CR4","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/gut.2004.061440","volume":"54","author":"PB Jeppesen","year":"2005","unstructured":"Jeppesen PB, Sanguinetti EL, Buchman A et al (2005) Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54:1224\u20131231. https:\/\/doi.org\/10.1136\/gut.2004.061440","journal-title":"Gut"},{"key":"5863_CR5","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.2147\/DMSO.S262284","volume":"13","author":"L Chen","year":"2020","unstructured":"Chen L, Zhang X, Zhang L et al (2020) Effect of saxagliptin, a dipeptidyl peptidase 4 inhibitor, on non-alcoholic fatty liver disease. Diabetes Metab Syndr Obes 13:3507\u20133518. https:\/\/doi.org\/10.2147\/DMSO.S262284","journal-title":"Diabetes Metab Syndr Obes"},{"key":"5863_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13098-021-00644-5","volume":"13","author":"S Hattori","year":"2021","unstructured":"Hattori S, Nomoto K, Suzuki T et al (2021) Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis. Diabetol Metab Syndr 13:28. https:\/\/doi.org\/10.1186\/s13098-021-00644-5","journal-title":"Diabetol Metab Syndr"},{"key":"5863_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00383-022-05301-0","volume":"39","author":"R Sueyoshi","year":"2022","unstructured":"Sueyoshi R, Furuhashi N, Ishii J et al (2022) Decreased liver damage in rat models of short bowel syndrome through DPP4 inhibition. Pediatr Surg Int 39:21. https:\/\/doi.org\/10.1007\/s00383-022-05301-0","journal-title":"Pediatr Surg Int"},{"key":"5863_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0148607113496280","volume":"38","author":"G Lauriti","year":"2014","unstructured":"Lauriti G, Zani A, Aufieri R et al (2014) Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review. JPEN J Parenter Enteral Nutr 38:70\u201385. https:\/\/doi.org\/10.1177\/0148607113496280","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"5863_CR9","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.31152","volume":"71","author":"RT Khalaf","year":"2020","unstructured":"Khalaf RT, Sokol RJ (2020) New insights into intestinal failure-associated liver disease in children. Hepatology 71:1486\u20131498. https:\/\/doi.org\/10.1002\/hep.31152","journal-title":"Hepatology"},{"key":"5863_CR10","doi-asserted-by":"publisher","first-page":"206ra137","DOI":"10.1126\/scitranslmed.3006898","volume":"5","author":"KC El Kasmi","year":"2013","unstructured":"El Kasmi KC, Anderson AL, Devereaux MW et al (2013) Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med 5:206ra137. https:\/\/doi.org\/10.1126\/scitranslmed.3006898","journal-title":"Sci Transl Med"},{"key":"5863_CR11","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00383-016-3975-1","volume":"32","author":"S Onishi","year":"2016","unstructured":"Onishi S, Kaji T, Yamada W et al (2016) The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome. Pediatr Surg Int 32:1165\u20131171. https:\/\/doi.org\/10.1007\/s00383-016-3975-1","journal-title":"Pediatr Surg Int"},{"key":"5863_CR12","doi-asserted-by":"publisher","first-page":"G610","DOI":"10.1152\/ajpgi.00184.2012","volume":"303","author":"AS Brinkman","year":"2012","unstructured":"Brinkman AS, Murali SG, Hitt S et al (2012) Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure. Am J Physiol Gastrointest Liver Physiol 303:G610\u2013G622. https:\/\/doi.org\/10.1152\/ajpgi.00184.2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5863_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.7326\/0003-4819-132-7-200004040-00003","volume":"132","author":"M Cavicchi","year":"2000","unstructured":"Cavicchi M, Beau P, Crenn P et al (2000) Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 132:525\u2013532. https:\/\/doi.org\/10.7326\/0003-4819-132-7-200004040-00003","journal-title":"Ann Intern Med"},{"key":"5863_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1055\/s-0036-1597771","volume":"37","author":"AL Buchman","year":"2017","unstructured":"Buchman AL, Naini BV, Spilker B (2017) The differentiation of intestinal-failure-associated liver disease from nonalcoholic fatty liver and nonalcoholic steatohepatitis. Semin Liver Dis 37:33\u201344. https:\/\/doi.org\/10.1055\/s-0036-1597771","journal-title":"Semin Liver Dis"},{"key":"5863_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0016-5085(93)90864-9","volume":"104","author":"EM Quigley","year":"1993","unstructured":"Quigley EM, Marsh MN, Shaffer JL et al (1993) Hepatobiliary complications of total parenteral nutrition. Gastroenterology 104:286\u2013301. https:\/\/doi.org\/10.1016\/0016-5085(93)90864-9","journal-title":"Gastroenterology"},{"key":"5863_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jhep.2010.11.021","volume":"55","author":"S Tandra","year":"2011","unstructured":"Tandra S, Yeh MM, Brunt EM et al (2011) Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol 55:654\u2013659. https:\/\/doi.org\/10.1016\/j.jhep.2010.11.021","journal-title":"J Hepatol"},{"key":"5863_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","volume":"49","author":"K Kaji","year":"2014","unstructured":"Kaji K, Yoshiji H, Ikenaka Y et al (2014) Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J Gastroenterol 49:481\u2013491. https:\/\/doi.org\/10.1007\/s00535-013-0783-4","journal-title":"J Gastroenterol"},{"key":"5863_CR18","doi-asserted-by":"publisher","first-page":"928371","DOI":"10.3389\/fnut.2022.928371","volume":"9","author":"F Di Dato","year":"2022","unstructured":"Di Dato F, Iorio R, Spagnuolo MI (2022) IFALD in children: what\u2019s new? A narrative review. Front Nutr 9:928371. https:\/\/doi.org\/10.3389\/fnut.2022.928371","journal-title":"Front Nutr"},{"key":"5863_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefevre","year":"2009","unstructured":"Lefevre P, Cariou B, Lien F et al (2009) Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89:147\u2013191. https:\/\/doi.org\/10.1152\/physrev.00010.2008","journal-title":"Physiol Rev"},{"key":"5863_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bbrc.2005.01.139","volume":"329","author":"S Katsuma","year":"2005","unstructured":"Katsuma S, Hirasawa A, Tsujimoto G (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329:386\u2013390. https:\/\/doi.org\/10.1016\/j.bbrc.2005.01.139","journal-title":"Biochem Biophys Res Commun"},{"key":"5863_CR21","doi-asserted-by":"publisher","first-page":"e000604","DOI":"10.1136\/bmjgast-2021-000604","volume":"8","author":"RM Naimi","year":"2021","unstructured":"Naimi RM, Hvistendahl MK, Thomassen LM et al (2021) Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study. BMJ Open Gastroenterol 8:e000604. https:\/\/doi.org\/10.1136\/bmjgast-2021-000604","journal-title":"BMJ Open Gastroenterol"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-024-05863-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-024-05863-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-024-05863-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:18:22Z","timestamp":1734023902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-024-05863-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5863"],"URL":"https:\/\/doi.org\/10.1007\/s00383-024-05863-1","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"16 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving animals were performed in accordance with the ethical standards of our institution and approved by the Institutional Review Board (certificate no. AE23-090).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"281"}}